Cell fusion corrects the 4-nitroquinoline 1-oxide sensitivity of Werner syndrome fibroblast cell lines

Human Genetics

Volumn 105, Issue 1-2, 1999, Pages 132-138

  Prince, Polly R ^a   Ogburn, Charles E ^a   Moser, Michael J ^a   Emond, Mary J ^a   Martin, George M ^a   Monnat Jr , Raymond J ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 NITROQUINOLINE 1 OXIDE; HELICASE; HYDROGEN PEROXIDE;

ARTICLE; ASSAY; CELL FUSION; CELL SURVIVAL; CONTROLLED STUDY; FIBROBLAST CULTURE; GAMMA RADIATION; HUMAN; HUMAN CELL; HYBRID CELL; PHENOTYPE; PRIORITY JOURNAL; WERNER SYNDROME;

EID: 0032808411     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004399900078     Document Type: Article

References (53)

1. Bennett SE, Umar A, Kodama S, Barrett JC, Monnat RJ Jr, Kunkel TA (1999) Evidence against a role for the Werner syndrome gene product in DNA mismatch repair. In: Bohr VA, Clark BFC, Stevnsner T (eds) Molecular biology of aging. Alfred Benzon Symposium 44, Copenhagen 1998. Munksgaard, Copenhagen, pp 214-224
2. Chen C, Okayama H (1987) High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 7:2745-2752
3. Coligan JE, Dunn BM, Ploegh HL, Speicher DW, Wingfield PT (1995) Current protocols in protein science. Wiley, New York
4. Daubersies P, Galiègue-Zouitina P, Koffel-Schwartz N, Fuchs RPP, Loucheux-Lefebvre H, Bailleul B (1992) Mutation spectra of the two guanine adducts of the carcinogen 4-nitroquinoline 1-oxide in Escherichia coli. Influence of neighboring base sequence on mutagenesis. Carcinogenesis 13:349-354
5. Epstein CJ, Martin GM, Schultz AL, Motulsky AG (1966) Werner's syndrome: a review of its symptomatology, natural history, pathologic features, genetics and relationship to the natural aging process. Medicine 45:177-221
6. Fronza G, Campomenosi P, Iannone R, Abbondandolo A (1992) The 4-nitroquinoline I-oxide mutational spectrum in single stranded DNA is characterized by guanine to pyrimidine transversions. Nucleic Acids Res 20: 1283-1287
7. Fronza G, Madzak C, Campomenosi P, Inga A, Iannone R, Abbondandolo A, Sarasin A (1994) Mutation spectrum of 4-nitroquinoline 1-oxide-damaged single-stranded shuttle vector DNA transfected into monkey cells. Mutat Res 308:117-125
8. Fukuchi K, Martin GM, Monnat RJ Jr (1989) Mutator phenotype of Werner syndrome is characterized by extensive deletions. Proc Natl Acad Sci USA 86:5893-5897
9. Gebhart E, Bauer R, Raub U, Schinzel M, Ruprecht KW, Jonas JB (1988) Spontaneous and induced chromosomal instability in Werner syndrome. Hum Genet 80:135-139
10. Giordano TJ, McAllister WT (1990) Optimization of the hygromycin B resistance-conferring gene as a dominant selectable marker in mammalian cells. Gene 88:285-288
11. Goto M (1997) Hierarchical deterioration of body systems in Werner's syndrome: implications for normal ageing. Mech Ageing Dev 98:239-254
12. Goto M, Horiuchi Y, Tanimoto K, Ishii T, Nakashima H (1978). Werner's syndrome: analysis of 15 cases with a review of the Japanese literature. J Am Geriatr Soc 26:341-347
13. Goto M, Miller RW, Ishikawa Y, Sugano H (1996) Excess of rare cancers in Werner syndrome (adult progeria). Cancer Epidemiol Biomarkers Prev 5:239-246
14. Gray MD, Shen J-C, Kamath-Loeb AS, Blank A, Sopher BL, Martin GM, Oshima J, Loeb LA (1997) The Werner syndrome protein is a DNA helicase. Nat Genet 17:100-103
15. Gray MD, Wang L, Youssoufian H, Martin GM, Oshima J (1998) Werner helicase is localized to transcriptionally active nucleoli of cycling cells. Exp Cell Res 242:487-494
16. Harris MJ, Juriloff DM (1998) Nonallelic noncomplementation models in mice: the first arch and lidgap-Gates mutations. Genome 41:789-796
17. Hartley HO, Rao JNK (1967) Maximum-likelihood estimation for the mixed analysis of variance model. Biometrika 54:93-108
18. Heitman J, Movva NR, Hall MN (1991) Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science 253:905-909
19. Herzing LBK, Meyn MS (1993) Novel LacZ-based recombination vectors for mammalian cells. Gene 137:163-169
20. Huang S, Li B, Gray MD, Oshima J, Mian IS, Campisi J (1998) The premature aging syndrome protein, WRN, is a 3′ → 5′ exonuclease. Nat Genet 20:114-116
21. Huschtscha LI, Thompson KVA, Holliday R (1986) The susceptibility of Werner's syndrome and other human skin fibroblasts to SV40-induced transformation and immortalization. Proc R Soc Lond [Biol] 229:1-12
22. Inga A, Iannone R, Degan P, Campomenosi P, Fronza G, Abbondandolo A, Menichini P (1994) Analysis of 4-nitroquinoline-1-oxide induced mutations at the hprt locus in mammalian cells: possible involvement of preferential DNA repair. Mutagenesis 9:67-72
23. Kamath-Loeb AS, Shen J-C, Loeb LA, Fry M (1998) Werner syndrome protein II: characterization of the integral 3′ → 5′ DNA exonuclease. J Biol Chem 273:34145-34150
24. Kodama S, Kashino G, Suzuki K, Takatsuji T, Okumura Y, Watanabe M, Barrett JC (1998) Failure to complement abnormal phenotypes of simian virus 40-transformed Werner syndrome cells by introduction of a normal human chromosome 8. Cancer Res 58:5188-5195
25. Marciniak RA, Lombard DB, Johnson FB, Guarente L (1998) Nucleolar localization of the Werner syndrome protein in human cells. Proc Natl Acad Sci USA 95:6887-6892
26. Martin GM (1978) Genetic syndromes in man with potential relevance to the pathobiology of aging. Birth Defects 14:5-39
27. Martin GM, Sprague CA, Epstein CJ (1970) Replicative life-span of cultivated human cells. Effects of donor's age, tissue, and genotype. Lab Invest 23:86-92
28. Matson SW, Bean DW, George JW (1994) DNA helicases: enzymes with essential roles in all aspects of DNA metabolism. BioEssays 16:13-22
29. Matsumura T, Nagata M, Konishi R, Goto M (1985) Studies of SV40-infected Werner syndrome fibroblasts. Adv Exp Med Biol 190:313-330
30. Monnat RJ Jr (1992) Werner syndrome: molecular genetics and mechanistic hypotheses. Exp Gerontol 27:447-453
31. Moser MJ, Oshima J, Monnat RJ Jr (1999) WRN mutations in Werner syndrome. Hum Mutat 13:271-279
32. Nagao M, Sugimura T (1976) Molecular biology of the carcinogen, 4-nitroquinoline 1-oxide. Adv Cancer Res 23:131-169
33. Norwood TH, Hoehn H, Salk D, Martin GM (1979) Cellular aging in Werner's syndrome: a unique phenotype? J Invest Dermatol 73:92-96
34. Nunoshiba T, Demple B (1993) Potent intracellular oxidative stress exerted by the carcinogen 4-nitroquinoline-N-oxide. Cancer Res 53:3250-3252
35. Ogburn CE, Oshima J, Poot M, Chen R, Hunt KE, Gollahon KA, Rabinovitch PS, Martin GM (1997) An apoptosis-inducing genotoxin differentiates heterozygotic carriers for Werner helicase mutations from wild-type and homozygous mutants. Hum Genet 101:121-125
36. Okada M, Goto M, Furuichi Y, Sugimoto M (1998) Differential effects of cytotoxic drugs on mortal and immortalized B-lymphoblastoid cell lines from normal and Werner's syndrome patients. Biol Pharm Bull 21:235-239
37. Pool M, Gollahon KA, Rabinovitch PS (1999). Werner syndrome lymphoblastoid cells are sensitive to camptothecin-induced apoptosis in S-phase. Hum Genet 104:10-14
38. Rancourt DE, Tsuzuki T, Capecchi MR (1995) Genetic interaction between hoxb-5 and hoxb-6 is revealed by nonallelic noncomplementation. Genes Dev 9:108-122
39. Rine J, Herskowitz I (1987) Four genes responsible for a position effect on expression from HML and HMR in Saccharomyces cerevisiae. Genetics 116:9-22
40. Rodolfo C, Lanza A, Torneletti S, Fronza G, Pedrini AM (1994) The ultimate carcinogen of 4-nitroquinoline 1-oxide does not react with Z-DNA and hyperreacts with B-Z junctions. Nucleic Acids Res 22:314-320
41. Ruiz-Laguna J, Ariza RR, Prieto-Alamo M-J, Boiteux S, Pueyo C (1994) Fpg protein protects Escherichia coli K-12 from mutation induction by the carcinogen 4-nitroquinoline 1-oxide. Carcinogenesis 15:425-429
42. Saito H, Moses RE (1991) Immortalization of Werner syndrome and progeria fibroblasts. Exp Cell Res 192:373-379
43. Salk D, Bryant E, Au K, Hoehn H, Martin GM (1981) Systematic growth studies, cocultivation, and cell hybridization studies of Werner syndrome cultured skin fibroblasts. Hum Genet 58: 310-316
44. Shen J-C, Gray MD, Oshima J, Kamath-Loeb AS, Fry M, Loeb LA (1998a) Werner syndrome protein I: DNA helicase and DNA exonuclease reside on the same polypeptide. J Biol Chem 273:34139-34144
45. Shen J-C, Gray MD, Oshima J, Loeb LA (1998b) Characterization of Werner syndrome protein DNA helicase activity: directionality, substrate dependence and stimulation by replication protein A. Nucleic Acids Res 26:2879-2885
46. Sinden RR (1994) DNA structure and function. Academic Press, San Diego
47. Stearns T, Botstein D (1988) Unlinked noncomplementation: isolation of new conditional-lethal mutations in each of the tubulin genes of Saccharomyces cerevisiae. Genetics 119:249-260
48. Suzuki N, Shimamoto A, Imamura O, Kuromitsu J, Kitao S, Goto M, Furuichi Y (1997) DNA helicase activity in Werner's syndrome gene product synthesized in a baculovirus system. Nucleic Acids Res 25:2973-2978
49. Tanaka K, Nakakzawa T, Okada Y, Kumahara Y (1979) Increase in DNA synthesis in Werner's syndrome cells by hybridization with normal human diploid and HeLa cells. Exp Cell Res 123: 261-267
50. Tanaka K, Nakazawa T, Okada Y, Kumahara Y (1980) Roles of nuclear and cytoplasmic environments in the retarded DNA synthesis in Werner syndrome cells. Exp Cell Res 127:185-190
51. Tollefsbol TO, Cohen HJ (1984) Werner's syndrome: an underdiagnosed disorder resembling premature aging. Age 7:75-88
52. Varkey JP, Jansma PL, Minniti AN, Ward S (1993) The Caenorhabditis elegans spe-6 gene is required for major sperm protein assembly and shows second site non-complementation with an unlinked deficiency. Genetics 133:79-86
53. Yu C-E, Oshima J, Fu Y-H, Wijsman EM, Hisama F, Ouais S, Nakura J, Miki T, Martin GM, Mulligan J, Schellenberg GD (1996) Positional cloning of the Werner's syndrome gene. Science 272:258-262